The FDA announced it will remove black box warnings from hormone replacement therapies after a 2002 study linked HRT to breast cancer. FDA Commissioner Marty Makary says the goal is to “stop the fear machine” and help women reclaim a therapy that could save lives. MORE: https://www.newsnationnow.com/politics/ap-politics/ap-fda-will-remove-long-standing-warning-from-hormone-based-menopause-drugs-citing-benefits-for-women/ | NewsNation